Literature DB >> 31486968

MRI-detected breast lesions: clinical implications and evaluation based on MRI/ultrasonography fusion technology.

Kazuaki Nakashima1, Takayoshi Uematsu2, Taiyo L Harada2, Kaoru Takahashi3, Seiichirou Nishimura3, Yukiko Tadokoro3, Tomomi Hayashi3, Junichiro Watanabe4, Takashi Sugino5.   

Abstract

Magnetic resonance imaging (MRI) is a highly sensitive imaging modality that frequently reveals additional breast lesions that are occult on mammography and ultrasonography (US) and are thus difficult to diagnose. It is important to investigate these MRI-detected suspicious lesions, which are associated with a fairly high rate of malignancy. In this review, we have discussed MRI/US fusion technology, a magnetic position tracking system that synchronizes real-time US and MRI to improve lesion detection and enables comparisons of MRI and US findings of the detected lesions. This combination increases the precision of second-look US. We hope that our review underscores the importance of understanding the US findings and histopathology of MRI-detected breast lesions, as this will enable radiologists to perform appropriate assessments.

Entities:  

Keywords:  Breast cancer; Fusion; MRI-detected lesion; Real-time virtual sonography; Second-look ultrasonography

Mesh:

Year:  2019        PMID: 31486968     DOI: 10.1007/s11604-019-00866-8

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  30 in total

1.  Utility of targeted sonography for breast lesions that were suspicious on MRI.

Authors:  Wendy B Demartini; Peter R Eby; Sue Peacock; Constance D Lehman
Journal:  AJR Am J Roentgenol       Date:  2009-04       Impact factor: 3.959

2.  MRI follow-up after concordant, histologically benign diagnosis of breast lesions sampled by MRI-guided biopsy.

Authors:  Jie Li; D David Dershaw; Carol H Lee; Jennifer Kaplan; Elizabeth A Morris
Journal:  AJR Am J Roentgenol       Date:  2009-09       Impact factor: 3.959

3.  Clinical Utility of Real-Time MR-Navigated Ultrasound with Supine Breast MRI for Suspicious Enhancing Lesions Not Identified on Second-Look Ultrasound.

Authors:  Doo Kyoung Kang; Yongsik Jung; Sehwan Han; Ji Young Kim; Tae Hee Kim
Journal:  Ultrasound Med Biol       Date:  2016-10-22       Impact factor: 2.998

4.  Real-time virtual sonography examination and biopsy for suspicious breast lesions identified on MRI alone.

Authors:  Takayoshi Uematsu; Kaoru Takahashi; Seiichiro Nishimura; Junichiro Watanabe; Seiji Yamasaki; Takashi Sugino; Takuma Oishi; Yuko Kakuda; Mutsu Sato; Tomomi Hayashi
Journal:  Eur Radiol       Date:  2015-07-03       Impact factor: 5.315

5.  Real-time virtual sonography (RVS)-guided vacuum-assisted breast biopsy for lesions initially detected with breast MRI.

Authors:  Takayoshi Uematsu
Journal:  Jpn J Radiol       Date:  2013-10-24       Impact factor: 2.374

6.  Magnetic resonance-guided vacuum-assisted breast biopsy: results in 100 Japanese women.

Authors:  Mitsuhiro Tozaki; Norie Yamashiro; Masaaki Sakamoto; Naomi Sakamoto; Nobuo Mizuuchi; Eisuke Fukuma
Journal:  Jpn J Radiol       Date:  2010-08-27       Impact factor: 2.374

7.  Use of a Volume Navigation Technique for Combining Real-Time Ultrasound and Contrast-Enhanced MRI: Accuracy and Feasibility of a Novel Technique for Locating Breast Lesions.

Authors:  Fikret Kucukkaya; Erkin Aribal; Derya Tureli; Hilal Altas; Handan Kaya
Journal:  AJR Am J Roentgenol       Date:  2016-01       Impact factor: 3.959

8.  MR-guided vacuum-assisted breast biopsy of MRI-only lesions: a single center experience.

Authors:  Claudio Spick; Melanie Schernthaner; Katja Pinker; Panagiotis Kapetas; Maria Bernathova; Stephan H Polanec; Hubert Bickel; Georg J Wengert; Margaretha Rudas; Thomas H Helbich; Pascal A Baltzer
Journal:  Eur Radiol       Date:  2016-03-16       Impact factor: 5.315

9.  A survey by the European Society of Breast Imaging on the utilisation of breast MRI in clinical practice.

Authors:  Paola Clauser; Ritse Mann; Alexandra Athanasiou; Helmut Prosch; Katja Pinker; Matthias Dietzel; Thomas H Helbich; Michael Fuchsjäger; Julia Camps-Herrero; Francesco Sardanelli; Gabor Forrai; Pascal A T Baltzer
Journal:  Eur Radiol       Date:  2017-11-22       Impact factor: 5.315

10.  Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography.

Authors:  Hiroaki Kawasoe; Yuichiro Eguchi; Toshihiko Mizuta; Tsutomu Yasutake; Iwata Ozaki; Tomonori Shimonishi; Kohji Miyazaki; Tsutomu Tamai; Akira Kato; Sho Kudo; Kazuma Fujimoto
Journal:  J Clin Biochem Nutr       Date:  2007-01       Impact factor: 3.114

View more
  5 in total

1.  Reply to the Letter to the Editor: MRI-detected breast lesions: clinical implications and evaluation based on MRI/ultrasonography fusion technology.

Authors:  Kazuaki Nakashima; Takayoshi Uematsu; Taiyo L Harada
Journal:  Jpn J Radiol       Date:  2019-11-08       Impact factor: 2.374

2.  MRI-detected breast lesions: clinical implications and evaluation based on MRI/ultrasonography fusion technology.

Authors:  Erkin Aribal
Journal:  Jpn J Radiol       Date:  2019-10-16       Impact factor: 2.374

3.  Second Look Ultrasonography-Guided Breast Biopsy with Magnetic Resonance Imaging Confirmation by Intralesional Contrast Injection.

Authors:  Yasemin Kayadibi; Fahrettin Kılıç; Ravza Yılmaz; Mehmet Velidedeoğlu; Tülin Öztürk; Deniz Esin Tekcan; Emel Ure Esmerer; Fatih Aydoğan; Mehmet Halit Yılmaz
Journal:  Eur J Breast Health       Date:  2020-12-24

4.  Forewarned Is Forearmed: Can Better Patient Counseling Increase MRI Utilization in High-Risk Women?

Authors:  Amy E Cyr; Ranjna Sharma
Journal:  Ann Surg Oncol       Date:  2020-08-09       Impact factor: 5.344

5.  Virtual Navigator Real-Time Ultrasound Fusion Imaging with Positron Emission Tomography/Computed Tomography for Preoperative Breast Cancer.

Authors:  Mio Mori; Kazunori Kubota; Tomoyuki Fujioka; Leona Katsuta; Yuka Yashima; Kyoko Nomura; Emi Yamaga; Junichi Tsuchiya; Tokuko Hosoya; Goshi Oda; Tsuyoshi Nakagawa; Iichiroh Onishi; Ukihide Tateishi
Journal:  Medicina (Kaunas)       Date:  2021-11-24       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.